
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolism and immunity in breast cancer
Deyu Zhang, Xiaojie Xu, Qinong Ye
Frontiers of Medicine (2020) Vol. 15, Iss. 2, pp. 178-207
Closed Access | Times Cited: 49
Deyu Zhang, Xiaojie Xu, Qinong Ye
Frontiers of Medicine (2020) Vol. 15, Iss. 2, pp. 178-207
Closed Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
The emerging role of PPAR-alpha in breast cancer
Zhiwen Qian, Lingyan Chen, Jiayu Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114420-114420
Open Access | Times Cited: 24
Zhiwen Qian, Lingyan Chen, Jiayu Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114420-114420
Open Access | Times Cited: 24
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 23
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 23
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 10
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 10
Landscape of metabolic alterations and treatment strategies in breast cancer
Xiujuan Wu, Xuanni Tan, Yangqiu Bao, et al.
Genes & Diseases (2025), pp. 101521-101521
Open Access | Times Cited: 1
Xiujuan Wu, Xuanni Tan, Yangqiu Bao, et al.
Genes & Diseases (2025), pp. 101521-101521
Open Access | Times Cited: 1
Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Chiara Francavilla, Ciara O’Brien
Open Biology (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 37
Chiara Francavilla, Ciara O’Brien
Open Biology (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 37
Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion
Jichun Lin, Wenshuo Fang, Zhuo Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Jichun Lin, Wenshuo Fang, Zhuo Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple‐negative breast cancer by stabilizing Snail1
Tangming Guan, Xiao Yang, Hui Liang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2992-3000
Closed Access | Times Cited: 23
Tangming Guan, Xiao Yang, Hui Liang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2992-3000
Closed Access | Times Cited: 23
m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
Xu Ke, Xiaojuan Dai, Jincheng Yue
Translational Oncology (2023) Vol. 36, pp. 101745-101745
Open Access | Times Cited: 14
Xu Ke, Xiaojuan Dai, Jincheng Yue
Translational Oncology (2023) Vol. 36, pp. 101745-101745
Open Access | Times Cited: 14
Image‐guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake
Qianlu Yang, Sisi Deng, Heike Preibsch, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 5
Qianlu Yang, Sisi Deng, Heike Preibsch, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 5
Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer
Yanfeng Wang, Jiaxin Fan, Yongcheng Liu, et al.
Aging (2024)
Open Access | Times Cited: 5
Yanfeng Wang, Jiaxin Fan, Yongcheng Liu, et al.
Aging (2024)
Open Access | Times Cited: 5
A review of contrast-enhanced ultrasound using SonoVue® and Sonazoid™ in non-hepatic organs
Qing Zhang, Xiaowen Liang, Yanfen Zhang, et al.
European Journal of Radiology (2023) Vol. 167, pp. 111060-111060
Closed Access | Times Cited: 12
Qing Zhang, Xiaowen Liang, Yanfen Zhang, et al.
European Journal of Radiology (2023) Vol. 167, pp. 111060-111060
Closed Access | Times Cited: 12
Advances in the clinical application of Raman spectroscopy in breast cancer
Mingyue Ma, Jiangbo Zhang, Ying Liu, et al.
Applied Spectroscopy Reviews (2024) Vol. 59, Iss. 10, pp. 1459-1493
Open Access | Times Cited: 4
Mingyue Ma, Jiangbo Zhang, Ying Liu, et al.
Applied Spectroscopy Reviews (2024) Vol. 59, Iss. 10, pp. 1459-1493
Open Access | Times Cited: 4
DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer
Hongliang Dong, Weiyi Jia, Weijian Meng, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Hongliang Dong, Weiyi Jia, Weijian Meng, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Effect of metabolism on the immune microenvironment of breast cancer
Yingming Zhou, Hu Wang, Yi Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 2, pp. 188861-188861
Open Access | Times Cited: 10
Yingming Zhou, Hu Wang, Yi Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 2, pp. 188861-188861
Open Access | Times Cited: 10
Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature
Lesang Shen, Huanhuan Huang, Jiaxin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Lesang Shen, Huanhuan Huang, Jiaxin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Challenges and Prospects in HER2-Positive Breast Cancer-Targeted Therapy
Xi‐Yin Li, Xueying Zhang, Saige Yin, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104624-104624
Open Access
Xi‐Yin Li, Xueying Zhang, Saige Yin, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104624-104624
Open Access
A novel fluorescence and colorimetric dual sensing system for rapid and sensitive detection of histidine based on TSPP-CA
D. Zou, Chih-Ming Lu, Yanyan Jia, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025), pp. 126145-126145
Closed Access
D. Zou, Chih-Ming Lu, Yanyan Jia, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025), pp. 126145-126145
Closed Access
Hydroxymethyltransferase 2 promotes the development of glioblastoma by mediating WTAP regulation of PTEN N6-methyladenosine modification
Meng Wang, Guangwei Sun, Yongzhong Fan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 5
Closed Access
Meng Wang, Guangwei Sun, Yongzhong Fan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 5
Closed Access
A Mendelian randomization study investigating the causal associations of 35 blood and urinary metabolite biomarkers with breast cancer development
Ting Hsiang Lin, Yimin Liu, Z. G. Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Ting Hsiang Lin, Yimin Liu, Z. G. Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
SREBP1-Dependent Metabolism as a Potential Target for Breast Cancer Risk Reduction
Atieh Hajirahimkhan, Kristy A. Brown, Susan E. Clare, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1664-1664
Open Access
Atieh Hajirahimkhan, Kristy A. Brown, Susan E. Clare, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1664-1664
Open Access
Lipid Metabolism Heterogeneity and Crosstalk with Mitochondria Functions Drive Breast Cancer Progression and Drug Resistance
Aurélien Azam, Nor Eddine Sounni
Cancers (2022) Vol. 14, Iss. 24, pp. 6267-6267
Open Access | Times Cited: 16
Aurélien Azam, Nor Eddine Sounni
Cancers (2022) Vol. 14, Iss. 24, pp. 6267-6267
Open Access | Times Cited: 16
Deciphering two decades of cellular reprogramming in cancer: A bibliometric analysis of evolving trends and research frontiers
Jinghao Liang, Yijian Lin, Yuanqing Liu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31400-e31400
Open Access | Times Cited: 3
Jinghao Liang, Yijian Lin, Yuanqing Liu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31400-e31400
Open Access | Times Cited: 3
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer
Xinxin Chen, Haojie Peng, Zhentao Zhang, et al.
Immunologic Research (2024) Vol. 72, Iss. 5, pp. 1030-1050
Closed Access | Times Cited: 3
Xinxin Chen, Haojie Peng, Zhentao Zhang, et al.
Immunologic Research (2024) Vol. 72, Iss. 5, pp. 1030-1050
Closed Access | Times Cited: 3
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
Ruiyuan Jiang, Ziru Fang, Huanping Zhang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7
Ruiyuan Jiang, Ziru Fang, Huanping Zhang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 7